Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Qiagen NV QGEN

Technology Scientific & Technical Instruments
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:QGEN)

QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis

GlobeNewswire 8 hours ago

QIAGEN collaborates with McGill University to advance microbiome research

GlobeNewswire November 12, 2024

QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook

GlobeNewswire November 6, 2024

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics

GlobeNewswire November 4, 2024

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment

GlobeNewswire October 29, 2024

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications

GlobeNewswire October 10, 2024

QIAGEN N.V. to release results for Q3 2024 and hold webcast

GlobeNewswire October 10, 2024

Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer

GlobeNewswire October 7, 2024

QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology

GlobeNewswire September 30, 2024
View More News ››

Opinion & Analysis (NYSE:QGEN)

Medigene, Memphasys, Qiagen - which stocks belong in the portfolio?

Stockhouse Editorial March 4, 2020
View More Opinion ››

Bullboard Posts (NYSE:QGEN)

Interview with Peer Schatz

CEO of QIAGEN N.V. Peer Schatz' interview is now online at Wall Street Reporter website
StockMaster1 - April 23, 2007
View more Bullboard ››

GameSquare Holdings Inc.

GameSquare Holdings Inc.

GameSquare Holdings, Inc. is a vertically integrated, digital media, entertainment and technology company. It connects global ...
View More »